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ARTICLE
Deletion of a Csf1r enhancer selectively impacts
CSF1R expression and development of tissue
macrophage populations
Rocío Rojo 1,2, Anna Raper 1, Derya D. Ozdemir1, Lucas Lefevre 1, Kathleen Grabert 1,3,
Evi Wollscheid-Lengeling1, Barry Bradford 1, Melanie Caruso 1, Iveta Gazova 1, Alejandra Sánchez1,
Zoﬁa M. Lisowski 1, Joana Alves 1, Irene Molina-Gonzalez 4, Hayk Davtyan 5, Rebecca J. Lodge6,
James D. Glover1, Robert Wallace7, David A.D. Munro8, Eyal David9, Ido Amit 9, Véronique E. Miron4,
Josef Priller8, Stephen J. Jenkins 6, Giles E. Hardingham8,10, Mathew Blurton-Jones 5, Neil A. Mabbott 1,
Kim M. Summers 11, Peter Hohenstein1,12, David A. Hume11,14 & Clare Pridans 6,13,14
The proliferation, differentiation and survival of mononuclear phagocytes depend on signals
from the receptor for macrophage colony-stimulating factor, CSF1R. The mammalian Csf1r
locus contains a highly conserved super-enhancer, the fms-intronic regulatory element (FIRE).
Here we show that genomic deletion of FIRE in mice selectively impacts CSF1R expression
and tissue macrophage development in speciﬁc tissues. Deletion of FIRE ablates macrophage
development from murine embryonic stem cells. Csf1rΔFIRE/ΔFIRE mice lack macrophages in
the embryo, brain microglia and resident macrophages in the skin, kidney, heart and peri-
toneum. The homeostasis of other macrophage populations and monocytes is unaffected, but
monocytes and their progenitors in bone marrow lack surface CSF1R. Finally, Csf1rΔFIRE/ΔFIRE
mice are healthy and fertile without the growth, neurological or developmental abnormalities
reported in Csf1r−/− rodents. Csf1rΔFIRE/ΔFIRE mice thus provide a model to explore the
homeostatic, physiological and immunological functions of tissue-speciﬁc macrophage
populations in adult animals.
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The proliferation, differentiation, and survival of vertebratemacrophages is controlled by signals from the macrophagecolony-stimulating factor (CSF1) receptor (CSF1R), enco-
ded by the c-fms protooncogene1, now known as Csf1r. The
function of the receptor and its two ligands, CSF1 and interleukin
34 (IL34), in macrophage differentiation is conserved in all
amniotes (i.e. reptiles, birds, and humans)2,3. Deletion of the
Csf1r locus in the mouse or rat germ line produces a global
deﬁciency in most tissue macrophage populations4,5. Mutant
animals are osteopetrotic (associated with loss of osteoclasts) and
exhibit severe postnatal growth retardation and multiple pleio-
tropic impacts on development. Tissue macrophages remain
dependent upon CSF1R in adult mice and can be depleted by
treatment with an inhibitory anti-CSF1R antibody6 or treatment
with orally available inhibitors of CSF1R kinase activity7. In
humans, dominant-negative mutations in the tyrosine kinase
domain are associated with an adult-onset neurodegenerative
disease8.
The expression of Csf1r mRNA is restricted to myeloid cells.
During embryonic development, Csf1r mRNA is expressed in the
earliest macrophages identiﬁable in the yolk sac and transcription
of this gene in pluripotent bone marrow (BM) progenitors is the
hallmark of commitment to the monocyte–macrophage lineage.
Accordingly, the molecular basis for myeloid-restricted tran-
scription regulation of Csf1r has been studied in considerable
detail (reviewed in ref. 9). The second intron, downstream of the
ﬁrst coding exon, contains a conserved 337bp sequence known as
the fms-intronic regulatory element (FIRE), identiﬁed as a super-
enhancer in genome-wide analysis of chromatin in mouse mac-
rophages. The mouse FIRE sequence contains binding sites for
numerous macrophage-expressed transcription factors9. The
combination of a 3.5 kb Csf1r promoter and intron 2, containing
FIRE, is sufﬁcient to direct reproducible transgenic reporter gene
expression in progenitors, monocytes, granulocytes, classical
dendritic cells, and tissue macrophages that also express Csf1r
mRNA10,11. Removal of FIRE from the reporter construct abol-
ishes expression10. The same Csf1r construct was used to drive
conditional Cre-recombinase in lineage-trace studies that dis-
sected the role of the yolk sac in macrophage development12. In
mammals, the FIRE sequence is more highly conserved than any
of the exons of the Csf1r gene13. A FIRE sequence is present in the
same relative intronic location of the Csf1r locus in all reptile and
bird species, and a core element required for enhancer activity14
is perfectly conserved13. The chicken CSF1R promoter and FIRE
sequences are also sufﬁcient to direct macrophage-speciﬁc
expression in chicken transgenic lines and to highlight the
appearance of the earliest phagocyte populations in the yolk sac15.
There have been relatively few studies of the function of
macrophage-speciﬁc enhancers in their genomic context. A
highly conserved upstream regulatory element that is present in
the Spi1 locus (which encodes the macrophage-speciﬁc tran-
scription factor PU.1) is required for regulated expression in
myeloid cells. Deletion of this element in the germline produces a
failure of myeloid differentiation and development of acute
myeloid leukemia16. Deletion of a super-enhancer within the
locus of the orphan nuclear receptor transcription factor (Nr4a1)
reveals its functional speciﬁcity, as only the LY6Clo monocytes are
lost, whilst the sensitivity of other monocyte and macrophage
subsets to pro-inﬂammatory stimuli is preserved17.
We aimed to determine the function of FIRE by deleting it
from the mouse germ line. If FIRE is essential for Csf1r tran-
scription, genomic deletion should partly or completely pheno-
copy the loss of tissue macrophages observed in Csf1r−/− mice.
Here we report that deletion of FIRE has an organ-speciﬁc effect
on Csf1r expression and macrophage differentiation. Despite the
lack of brain microglia and resident macrophages in skin, heart,
kidney, and peritoneum, Csf1rΔFIRE/ΔFIRE mice are healthy and
fertile. Aside from highlighting the likely function of other reg-
ulatory elements in the Csf1r locus, these mice provide a model to
explore tissue-speciﬁc macrophage transcriptional regulation and
function.
Results
In vitro validation of CRISPRs targeting the FIRE sequence.
Guide RNAs (gRNAs) designed to delete FIRE (Fig. 1a) were ﬁrst
validated in the RAW 264.7 macrophage cell line and in E14
mouse embryonic stem cells (ESC). The macrophage cell line
expresses Csf1r mRNA and was used in all of the transfection
studies that previously led to the characterization of the role of
FIRE14. Both cell types were co-transfected with pairs of Cas9-2A-
EGFP constructs each expressing single gRNAs (US1+DS1 or
DS2), and pools of EGFP+ cells were screened via PCR to detect
the deletion of FIRE mediated by the CRISPR/Cas9 system. Both
pairs of gRNAs produced deletions in E14 ESC and RAW 264.7
cells (Supplementary Fig. 1a). The deletion of FIRE and the ab-
sence of mismatches in the remaining Csf1r sequence in E14 ESC
were conﬁrmed by Sanger sequencing (Supplementary Fig. 1b). In
RAW 264.7 macrophage cells, individual Csf1rΔFIRE/ΔFIRE clones
carried slightly different deletions of the FIRE sequence (Supple-
mentary Fig. 1c). RAW 264.7 cells are not CSF1R-dependent and
most of the cellular CSF1R protein is retained in the Golgi
apparatus. We therefore analyzed cell-associated CSF1R by ﬂow
cytometry in permeabilized cells. The deletion of FIRE completely
ablates detectable intracellular CSF1R (Fig. 1b). There is no impact
of the FIRE mutation on cell morphology (Fig. 1c) or phagocytic
capacity of cells (Fig. 1d). Neither the frequency nor the median
ﬂuorescence intensity (MFI) of the macrophage surface marker
F4/80 distinguishes between Csf1r+/+ and Csf1rΔFIRE/ΔFIRE clones
(Fig. 1e). We conclude that FIRE is required speciﬁcally for the
expression of CSF1R in the RAW 264.7 macrophage cell line.
E14 mouse ESC can be cultured in the absence of feeders and
form embryoid bodies (EB)18 with the potential to generate cells
belonging to all the primary embryonic germ layers (i.e.
endoderm, mesoderm, and ectoderm). Macrophage differentia-
tion from EB was induced by supplementing culture medium
with murine IL3 (mIL3) and recombinant human CSF1
(rhCSF1). Csf1rΔFIRE/ΔFIRE mouse ESC generated using the
gRNA pair US1+DS2 are able to produce EB that are
indistinguishable from the controls (Fig. 1f, Day 0). By day 7,
they give rise to cells that attach to culture plates, indicating that
the deletion of FIRE does not affect responsiveness to IL3. By
2 weeks post-differentiation, a lawn of ESC-derived macrophages
are produced from the Csf1r+/+ EB, whereas the number of
macrophages from Csf1rΔFIRE/ΔFIRE clones was ≈200-fold lower
(Fig. 1f). Overall, these in vitro results indicate that FIRE is
required for expression of Csf1r and/or macrophage
differentiation in EB.
Generation of Csf1rΔFIRE/ΔFIRE mice. To produce
Csf1rΔFIRE/ΔFIRE mice, vectors encoding the FIRE gRNAs US1 and
DS2 and Cas9 were microinjected into C57BL/6J/CBA F1 mouse
oocytes. One male founder with the expected 418 bp deletion was
crossed with Csf1r+/+ C57BL/6J females and the progeny were
interbred. The frequencies of Csf1r+/+, Csf1r+/ΔFIRE and
Csf1rΔFIRE/ΔFIRE mice at weaning are 26%, 55%, and 19%,
respectively (n= 501). Unlike Csf1r−/− mice or the Csf1op/op
mouse4 there is no postnatal growth retardation, failure of tooth
eruption or evidence of osteopetrosis in Csf1rΔFIRE/ΔFIRE
mice (Fig. 2a–c). The proximal growth plates of control and
Csf1rΔFIRE/ΔFIRE mice are indistinguishable and normal numbers
of osteoclasts are present (Fig. 2d, e). Brain abnormalities
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in Csf1r−/− mice include reduced brain size, severely enlarged
ventricles, hollow olfactory bulbs, deﬁcient myelination and
failure of commissure closing in the corpus callosum19. The
Csf1rΔFIRE/ΔFIRE brains are not macroscopically distinguishable
from controls and Luxol fast blue staining reveals no differences in
myelination (Fig. 2f, g).
Csf1op/op, Csf1r−/− mice and adult mice treated with anti-
CSF1R antibody lack lamina propria and Peyer’s patch macro-
phages in the small intestine. These mice also show associated
changes in villus architecture, increased goblet cell numbers
detected with periodic acid-schiff (PAS) staining, reduced
proliferation in the crypts and defects in differentiation of Paneth
cells6,20,21. Csf1r mRNA is not expressed in intestinal epithelial
cells and the impacts of anti-CSF1R treatment are attributable to
the loss of macrophages surrounding the crypts21. There are no
detectable alterations in intestinal epithelia that distinguish
between Csf1r+/+ and Csf1rΔFIRE/ΔFIRE mice (Fig. 2h and
Supplementary Fig. 2).
The development of normal sexual maturity is compromised in
both male and female Csf1op/op mice22,23 and in Csf1r−/− rats5.
By contrast, the Csf1rΔFIRE/ΔFIRE mice reach sexual maturity and
are fertile.
The impact of FIRE deletion in blood and BM. Two subsets of
blood monocytes can be distinguished based upon the expression
of LY6C. The differentiation of the LY6Clo subset depends upon
CSF1R signaling6,24. Csf1rΔFIRE/ΔFIRE mice have normal cell
populations in peripheral blood (Fig. 3a) and F4/80, LY6C, and
CD11b expression is unchanged compared to littermates
(Fig. 3b–d). However, the expression of CSF1R detected with
anti-CD115 antibody is abolished (Fig. 3c). Furthermore, the
binding of labeled CSF1 (pCSF1-FcAF647)11 is undetectable in the
mutant mice, whereas in littermates it provides a sensitive marker
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Fig. 1 FIRE deletion reduced CSF1R expression and prevented macrophage differentiation. a Schematic of Csf1r gene and location of gRNAs (US1, DS1, DS2),
targeting FIRE. Protospacer adjacent motifs (PAM) are located to the right of each gRNA. Black boxes= coding exons, white boxes= untranslated regions,
lines connecting exons= intronic sequences, yellow and green arrows= trophoblast/osteoclast promoter and macrophage transcription start sites,
respectively. b Flow cytometry analysis of total CSF1R in ﬁxed and permeabilized RAW 264.7 cell clones. Histograms are representative of three clones per
genotype, from two repeat experiments in duplicate. MFI median ﬂuorescence intensity, black line=+/+, gray line=Δ/Δ, dotted line= isotype control.
P≤ 0.0001 (****). c CRISPR-treated Csf1r+/+ and Csf1rΔFIRE/ΔFIRE RAW 264.7 cells cultured in vitro. Scale bar= 50 µm. d A phagocytosis assay was
performed with RAW 264.7 cells and pHrodo® Red E. coli BioParticles® followed by ﬂow cytometry analysis. n= 4 clones per genotype from two repeat
experiments. MFI median ﬂuorescence intensity. e Flow cytometry analysis of surface F4/80 in RAW 264.7 cell clones. Histograms are representative of
three clones per genotype from two repeat experiments in duplicate. f Csf1r+/+ and Csf1rΔFIRE/ΔFIRE E14 ESC clones were differentiated into macrophages
with mIL3 and rhCSF1. Scale bars= 200 µm (Day 0, embryoid bodies) and 50 µm (Days 7 and 14). n= 3 clones per genotype, P= 0.005 (**). All source
data are provided within a Source Data excel ﬁle. Graphs show mean+ SEM and P values were determined by two-tailed t-tests
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for F4/80+ blood monocytes (Fig. 3d). Notably, the level of both
CSF1R and CSF1 binding is reduced by around 50% in the het-
erozygotes (Fig. 3c, d), which is consistent with a lack of dosage
compensation at the mRNA level also reported in Csf1r-deﬁcient
mice and rats4,5.
Unlike Csf1r and Csf1 mutant mice4, Csf1rΔFIRE/ΔFIRE mice are
not osteoclast-deﬁcient and osteopetrotic. Total BM cellularity
remains unchanged by the FIRE mutation (Supplementary Fig. 3a).
Aside from progenitors, BM contains multiple specialized macro-
phage populations that regulate bone homeostasis and hematopoietic
differentiation (reviewed in ref. 25). BM cell populations were
analyzed by ﬂow cytometry as described in Supplementary Fig. 3b.
Two populations of F4/80+ cells are detected in control mice that
differed in the level of CSF1R. The proportion of F4/80+ cells is
unchanged in Csf1rΔFIRE/ΔFIRE mice, but CSF1R expression and
CSF1 binding is abolished in both F4/80+ populations (Supplemen-
tary Fig. 3c and d). As in the blood, the level of CSF1R is reduced
around 50% in heterozygotes. BM contains a population of
monocyte–dendritic cell progenitors (MDP) that express KIT,
FLT3, and CSF1R, and committed proliferative LY6C+ progenitors
derived from the MDP that lack both KIT and FLT326. Although
CSF1R expression is lost in Csf1rΔFIRE/ΔFIRE BM, there is no
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reduction in the number of cells expressing LY6C, KIT, or FLT3
(Supplementary Fig. 3e). In view of the apparent loss of CSF1R
protein, we examined whether BM frommutant mice is responsive to
CSF1. BM-derived macrophages (BMDM) are generated from
Csf1rΔFIRE/ΔFIRE BM, but with greatly reduced yield compared to
controls (Supplementary Fig. 3f). The macrophages derived from
Csf1rΔFIRE/ΔFIRE BM still express F4/80 and CD11b but have lower
levels of surface CSF1R detected with pCSF1-FcAF647 relative to
controls (Supplementary Fig. 3g). Hence, the production/survival of
these few BMDM relies on some mechanism that compensates for
the absence of FIRE.
Macrophage populations in Csf1rΔFIRE/ΔFIRE mice. We per-
formed ﬂow cytometry and/or immunohistochemistry analyses
on major organs as shown in Fig. 4, Supplementary Figs. 4 and 5.
Liver macrophages (Kupffer cells, KC) are CSF1R-dependent4,6,
CSF1-responsive27, and the main site of clearance of labeled
CSF111. The number, location, or morphology of KC and the
liver-to-body weight ratio of Csf1rΔFIRE/ΔFIRE mice are similar to
littermate controls (Supplementary Fig. 4a, b). Flow cytometry
analysis conﬁrmed the unchanged numbers of KC and dendritic
cell subsets (cDC2 as deﬁned previously11) (Fig. 4a) and retention
of KC-speciﬁc markers such as TIM4 (Supplementary Fig. 4c).
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However, there is a signiﬁcant increase in LY6Clo monocyte-like
cells (CD11b+F4/80lo). The full gating strategy for liver ﬂow
cytometry data is shown in Supplementary Fig. 4d.
The marginal zone is completely absent in the spleen of Csf1op/op
mice28 and in Csf1r−/− rats5. In Csf1rΔFIRE/ΔFIRE mice the overall
architecture and relative area of the marginal zone is
indistinguishable from the controls (Supplementary Fig. 4e and f).
As in the liver, there is no change in the spleen-to-body weight ratio
or the relative abundance of myeloid populations deﬁned by
staining for F4/80+ or other markers (Supplementary Fig. 4g, h and
Fig. 4b). The full gating strategy for spleen ﬂow cytometry data is
shown in Supplementary Fig. 4i.
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Lung macrophage populations are primarily controlled by
CSF2 (also known as GM-CSF, encoded by Csf2), rather than
CSF129, but lung macrophages do express Csf1r and bind CSF111.
The Csf1r-EGFP macrophage-reporter transgene is highly
expressed in both alveolar (AM) and interstitial macrophage
populations in the lung10, which have distinct developmental
origins and renewal mechanisms during adulthood30. Further-
more, expression of Csf1r-EGFP in AM is dependent upon the
inclusion of FIRE in the transgene10. Macrophages of the lung are
partly depleted in Csf1op/op mice31 and double mutant Csf1op/op
and Csf2−/− mice develop severe alveolar proteinosis29. AM can
be identiﬁed based upon expression of SIGLECF30. Interstitial
myeloid populations have been classiﬁed as macrophage and
conventional dendritic cell subpopulations, based upon expres-
sion of CD64, CD11b, CD11c, and MHCII11. To assess the
impact of the FIRE deletion on these populations, lungs were
digested and analyzed by ﬂow cytometry as previously
described11. The full gating strategy is shown in Supplementary
Fig. 5a. We also measured Csf1r mRNA in the lung of wild-type
and Csf1rΔFIRE/ΔFIRE mice (Supplementary Fig. 5b). FIRE
deletion has no effect on AM or any of the interstitial myeloid
populations of the lung (Fig. 4c). A marginal reduction in Csf1r
mRNA is likely attributable to the loss of expression in monocytes
in both blood and BM (Fig. 3c, d and Supplementary Fig. 3c, d).
F4/80 is barely detectable in either of the major lung macrophage
populations and is primarily associated with monocytes30.
Accordingly, the levels of total Adgre1 (encoding F4/80) and
Itgam (CD11b) mRNA in the lung are unaffected by the deletion
of FIRE. We conclude that FIRE is not required for expression of
Csf1r mRNA in lung macrophages nor for their development or
monocyte trafﬁcking in the lung.
The large macrophage population of the intestine is constantly
renewed from recruited blood monocytes32. The Peyer’s patch
and surrounding mucosa contain several specialized mononuclear
phagocyte populations, distinguished by mRNA or protein
expression of the surface markers F4/80 (ADGRE1), CD4,
SIGLEC1, SIRPA, MERTK, TIM4, CX3CR1, and ITGAX
(CD11c)33, including a recently described long-lived
population34,35. All of these populations depend upon continuous
CSF1R signaling6,21. Monocytes enter the lamina propria
constantly and respond to the local environment with progressive
changes in surface phenotype and gene expression in a so-called
monocyte waterfall32. Supplementary Fig. 6 shows the compar-
ison of these populations in the Csf1r+/+ and Csf1rΔFIRE/ΔFIRE
mice. There is no detectable difference in distribution of
monocyte-like, DC-like, or macrophage populations in either
small or large intestine.
Macrophages are so abundant in the intestine that the level of
macrophage-speciﬁc transcripts can be reproducibly detected by
analysis of total mRNA. To complement the analysis of isolated
cells, we isolated mRNA from Peyer’s patches and surrounding
mucosa in the ileum of Csf1r+/+ and Csf1rΔFIRE/ΔFIRE mice and
proﬁled gene expression using microarrays. There is no
signiﬁcant difference in Csf1r expression between Csf1r+/+ and
Csf1rΔFIRE/ΔFIRE mice nor in the level of mRNA encoding any of
the markers of intestinal macrophage subpopulations mentioned
above, including Itgam (CD11b) and Ly6c1, which are rapidly
down-regulated following extravasation into the intestine32
(Supplementary Data 1). These ﬁndings demonstrate that FIRE
is not required by intestinal macrophages for expression of Csf1r
and that the loss of CSF1R in monocytes has no impact on
intestinal macrophage homeostasis. In addition, the expression of
transcripts that mark cell types controlled indirectly by signals
from CSF1R-dependent macrophages, including markers of
Paneth cells (Lyz1), microfold cells (Spib, Ccl9, Tnfrsf11a) or
goblet cells (Muc2)21, are unaffected (Supplementary Data 1).
Loss of macrophage populations in Csf1rΔFIRE/ΔFIRE mice. The
resident macrophages of the peritoneal cavity may be subdivided
into two populations, based upon relative size and the level of
TIM4 and F4/80 antigen they express36. Both populations of
peritoneal macrophages (PM) are absent from Csf1op/op and
Csf1r−/− mice4,28 and from mice treated with anti-CSF1R anti-
body6. The major TIM4+F4/80hiCD11bhi large PM population is
almost entirely lost in Csf1rΔFIRE/ΔFIRE mice (Fig. 5a and Sup-
plementary Fig. 6a). The minor residual PM population consists
of the small PM that are TIM4−F4/80lo36. These cells were shown
previously to bind labeled CSF1 preferentially compared to large
PM11. Both anti-CSF1R (CD115) and CSF1-Fc binding to these
residual populations are absent in the Csf1rΔFIRE/ΔFIRE mice
(Fig. 5a). In Csf1rΔFIRE/+ mice the PM populations are retained
but as in blood and BM, there is a reduction in the level of surface
receptor detected with either labeled CSF1 or anti-CSF1R anti-
body, which is consistent with the lack of dosage compensation.
In summary, in the peritoneum, the Csf1rΔFIRE/ΔFIRE mutation
phenocopies the Csf1r-deﬁcient mice.
The abundant interstitial F4/80hi macrophage populations of
the kidney have recognized roles in renal growth and
development37, homeostasis and immune surveillance38.
F4/80hi kidney macrophages were almost absent from both
Csf1op/op and Csf1r−/− mice4. To identify populations of renal
mononuclear phagocytes we enzymatically digested kidneys and
analyzed CD45+ myeloid cells by ﬂow cytometry. The gating
strategy is shown in Supplementary Fig. 7b. Csf1rΔFIRE/ΔFIRE
mice have fewer total CD45+ cells and the F4/80hiCD11blo
resident kidney macrophages (KM)38 are undetectable (Fig. 5b).
In both control and mutant, a subset of the CD11bhi cells are F4/
80loMHCII− monocytes but the majority of cells in the F4/
80loCD11bhi (R1) gate are also MHCII+/CD64+. Their surface
phenotype is reminiscent of the monocyte-derived small PM
discussed above. As in the peritoneum, their abundance is
slightly increased by the FIRE mutation (Fig. 5b). Conventional
dendritic cells (cDC) in the kidney are difﬁcult to separate from
macrophages based upon surface markers. A minor subpopula-
tion of cDC (F4/80−CD11b+MHCII+) is detected in both
control and Csf1rΔFIRE/ΔFIRE kidneys (R2 gate) (Fig. 5b).
Although exogenous CSF1 can promote mouse kidney morpho-
genesis in vitro and growth of the kidney in vivo37, there is no
change in the kidney-to-body weight ratio in Csf1rΔFIRE/ΔFIRE
mice (Supplementary Fig. 7c) and kidneys are histologically
normal (Supplementary Fig. 7d).
Macrophages of the heart can also be separated into
subpopulations attributed distinct roles in cardiac homeostasis
and repair following injury39–41. Supplementary Fig. 7e shows the
ﬂow cytometry gating strategy for the heart and Fig. 5c
summarizes the analysis of digested cardiac macrophage popula-
tions from control and Csf1rΔFIRE/ΔFIRE mice. The total cardiac
CD45+ population is greatly reduced in the Csf1rΔFIRE/ΔFIRE
mice due to selective loss (70–80%) of both the F4/80hiCD64+
macrophage (MHCIIhi) and monocyte-like (MHCIIlo) popula-
tions previously described by others39–41. Interestingly, a recent
study proposed a link between resident macrophages of the
kidney and the heart in the generation of an adaptive response to
cardiac pressure overload40. However, as in the kidney, we detect
no change in the heart-to-body weight ratio in Csf1rΔFIRE/ΔFIRE
mice (Supplementary Fig. 7f) and the histology is indistinguish-
able from controls (Supplementary Fig. 7g).
There are two major macrophage populations in the skin, the
Langerhans cells of the epidermis and the dermal macrophages.
Both are CSF1R-dependent4,6 but Langerhans cells, like micro-
glia, depend speciﬁcally on the alternative CSF1R ligand, IL3442.
Langerhans cells are absent in epidermal sheets from tails of
Csf1rΔFIRE/ΔFIRE mice (Fig. 6a). The loss of this cell population
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has no effect on the morphology of the epidermis or the dermis
(Fig. 6b). Dermal macrophage populations accumulate melano-
somes from neighboring melanocytes and, like macrophages of
the gut, they turn over rapidly43. The stellate melanophagic
macrophage populations of the dermis are F4/80+ and are not
affected by the FIRE mutation (Fig. 6b).
Loss of microglia in Csf1rΔFIRE/ΔFIRE mice. Microglia, the
tissue-resident macrophage population of the brain, arise very
early in mouse embryonic development and depend upon CSF1R
signaling44. Microglia detected by localization of IBA1 or
P2RY12 in littermate controls are absent in the brain of
Csf1rΔFIRE/ΔFIRE mice (Fig. 7a, b). Disaggregation of the whole
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Fig. 5 FIRE deletion results in loss of macrophages in the peritoneal cavity, kidney, and heart. a Flow cytometry proﬁles show peritoneal cells from
representative Csf1r+/+ and Csf1rΔFIRE/ΔFIRE mice using the gating strategy described by Bain et al.36. Small peritoneal macrophages (SPM) were identiﬁed
as F4/80loCD11b+ and large peritoneal macrophages (LPM) as F4/80hiCD11b+ (Panel 1). These populations were analyzed for CSF1R expression (Panel 2)
and binding of pCSF1-Fc (Panel 3). n= 8+/+, 6+/Δ and 9 Δ/Δ mice aged between 10 and 15 weeks, from ﬁve experiments. P= 0.012–0.048 (*),
0.002–0.006 (**), 0.001 (***) and <0.0001 (****). b Leukocyte populations were isolated from enzymatically digested kidneys and gated for CD45
expression. The ﬂow cytometry proﬁles show analysis of representative Csf1r+/+ and Csf1rΔFIRE/ΔFIRE mice. Kidney macrophages (KM) were identiﬁed as
F4/80hiCD11blo (Panel 1), pooled LY6C−/+ monocytes (Mo) as F4/80loMHCII− (Panel 2), putative monocyte-derived macrophages as F4/80loMHCII+
(Panel 2), and conventional dendritic cells (cDC) as F4/80−CD11bloMHCII+ (Panel 3). n= 5 mice per genotype aged 8–10 weeks, from three experiments.
P= 0.015 (*) and 0.0001 (***). c Single cell suspensions of enzymatically digested hearts from the same cohort were analyzed by ﬂow cytometry. Cells
were gated lineage− (Lin−= CD3/CD19/LY6G). n= 6+/+ and 5 Δ/Δ from three experiments. MΦ macrophage, Mo monocyte. P= 0.009 (**), 0.0003
(*** MΦ), and 0.0001 (*** CD11b+). All source data are provided within a Source Data excel ﬁle. Graphs show mean+ SEM and P values were determined
by two-tailed t-tests
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brain and analysis by ﬂow cytometry45 conﬁrms the loss of
CD45low/CD11b+ microglia which persists up to 9 months of
age (Fig. 7c). The full ﬂow cytometry gating strategy is shown in
Supplementary Fig. 8a. Heterozygous mutation (haploinsufﬁ-
ciency) of Csf1r has been proposed as a model for the human
neurodegenerative disease ALSP (adult onset leukoencephalo-
pathy with axonal spheroids and pigmented glia)46. However,
there is no detectable effect of the heterozygous mutation in mice
(Csf1rΔFIRE/+) on microglial numbers. The brain also contains
populations of CD45hi classical macrophages associated with
the vasculature, meninges, and choroid plexus with a distinct
transcriptional proﬁle47,48. CD45hi cells are retained in
Csf1rΔFIRE/ΔFIRE brain digests (Fig. 7c) This was conﬁrmed by
immunolocalization of CD169, shown recently to be a marker
alongside CD206 and LYVE1 for a perivascular macrophage
population in most tissues49 (Fig. 7d, e). The brain-to-body
weight ratios in adult male and female Csf1rΔFIRE/ΔFIRE mice
remains unchanged (Supplementary Fig. 8b).
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Microglia are so abundant in the brain that their gene
expression proﬁle is readily detected in total mRNA. The
complete loss of microglia in Csf1r−/− rat brains was associated
with commensurate loss of known microglia-associated tran-
scripts in four brain regions5. To conﬁrm the loss of microglia
we compared the gene expression proﬁles of Csf1rΔFIRE/ΔFIRE
and Csf1r+/+ hippocampi. The results, including ANOVA
analysis of signiﬁcantly regulated transcripts, are contained
within Supplementary Data 2. Overall, 85 genes are signiﬁcantly
downregulated in the Csf1rΔFIRE/ΔFIRE mouse hippocampus
and 77 genes from this group (including Csf1r) have been
previously shown to be expressed in human and mouse
microglia45,50,51. Of the top 35 transcripts found by Elmore
and colleagues to be down-regulated in the brains of adult mice
treated with a CSF1R kinase inhibitor52, 26 are also signiﬁcantly
reduced in the hippocampus of Csf1rΔFIRE/ΔFIRE mice. The gene
set affected by the Csf1rΔFIRE/ΔFIRE mutation includes a small
set of novel genes that may be implicated in microglial biology.
Amongst these, the immune checkpoint protein, VISTA (Vsir),
was recently localized in both human and mouse and was
attributed functions in CNS pathologies53. In addition, HVCN1
was previously shown to regulate the production of microglial
reactive oxygen species54. Consistent with the retention of the,
CD45hiCD11b+CD169+ brain macrophage population in the
Csf1rΔFIRE/ΔFIRE mice (Fig. 7b–e), Ptprc (encoding CD45
antigen) and myeloid markers, such as Mrc1(Cd206), Siglec1,
Siglecf, Cd163, Csf2ra/b/b2, Fcgr2b, Tnfrfsf11a (RANK) that
have all been associated with these populations47,48 are not
signiﬁcantly affected by the deletion of FIRE (Supplementary
Data 2). The complete loss of detectable Csf1r expression
implies that the perivascular and brain-associated macrophages,
like blood monocytes and the macrophages of the BM, have lost
Csf1r expression but are nevertheless produced normally.
Microglia have been implicated in oligodendrocyte maturation
and synaptic plasticity55. The loss or induced depletion of
microglia in other models leads to alterations in synaptic pruning,
hippocampal neurogenesis, myelination, oligodendrocyte matura-
tion, and astrocyte activation56. By contrast to phenotypes
reported in Csf1op/op and Csf1r−/− mice4, we observe no evidence
of auditory or visual abnormalities in the Csf1rΔFIRE/ΔFIRE mice.
Sensory neuronal deﬁcits have been associated with deﬁcient
hippocampal neurogenesis but in the Csf1rΔFIRE/ΔFIRE mice there
is no loss of expression of markers associated with neuronal
progenitor cells (such as doublecortin (Dcx), and Sox257)
(Supplementary Data 2). Nandi et al.58 claimed that Csf1r is
expressed in subsets of neuronal progenitors, and noted the
relative loss of excitatory neurons, expressing Cux1 or Ctip2
(BCll1b) in the Csf1r−/− mouse brain. CUX1 mRNA was also
reduced in the brain in a recently described human patient with a
homozygous CSF1R mutation59. Neither transcript is down-
regulated in the hippocampus of Csf1rΔFIRE/ΔFIRE mice (Supple-
mentary Data 2).
Zhang et al.60 used expression proﬁles of isolated cells to
identify a set of signatures of brain cell populations that can
support deconvolution of whole brain expression data. As
shown in Supplementary Fig. 8c, there is no signiﬁcant effect
of the Csf1rΔFIRE/ΔFIRE mutation on any cell-type-speciﬁc
signature (neuron, astrocyte, oligodendrocyte, endothelium)
other than microglia. The lack of impact on astrocyte numbers
or morphology was conﬁrmed by immunolocalization of the
speciﬁc markers GFAP and SOX9 in the hippocampus, as well
as the striatum, olfactory bulbs, and cerebellum (Supplemen-
tary Fig. 8d). Whereas microglia have been implicated as
major sources of trophic factors, mRNA expression of Bdnf,
Igf1, Tgfb1,2, and 3 is not affected by the absence of microglia
in Csf1rΔFIRE/ΔFIRE mice (Supplementary Data 2). Similarly,
macrophages and microglia selectively express very high levels
of lysosomal-associated genes (e.g. Lamp1, Ctsb, Atp6v0e) and
receptors for apoptotic cells (e.g. Mertk, Axl) compared to
whole brain regions (e.g. see biogps.org) but the loss of
microglia has no effect on the expression of any lysosome-
associated transcripts in the hippocampus of Csf1rΔFIRE/ΔFIRE
mice. This conclusion is consistent with the proposal that
astrocytes are potentially also engaged with apoptotic cell
clearance61 and might ﬁll this role in the absence of microglia.
Embryonic macrophage development in Csf1rΔFIRE/ΔFIRE mice.
Many tissue resident macrophages are seeded during embryonic
development from the yolk sac and fetal liver
progenitors24,30,41,44,62,63. Csf1r−/− mice lack yolk sac-derived
macrophages and microglia but develop fetal monocytes44.
Treatment of a pregnant mouse with anti-CSF1R resulted in the
loss of embryonic macrophages derived from the yolk sac,
whereas circulating liver-derived monocytes were unaffected63.
As shown in Fig. 8a the Csf1rΔFIRE/ΔFIRE embryos develop nor-
mally but the overall density of IBA1+ macrophages throughout
the body is greatly reduced. In the critical window in which liver
hematopoiesis is established and the blood–brain barrier is closed
(embryonic day 12–13), IBA1+ ameboid microglia are prevalent
in controls but undetectable in Csf1rΔFIRE/ΔFIRE embryos
(Fig. 8b–d). Numerous macrophages expressing the CSF1R-ECFP
and CSF1R-EGFP reporter genes line the ventricular and external
surfaces of the developing brain from 9.5 dpc10,64. These cells are
absent in Csf1rΔFIRE/ΔFIRE embryos (Fig. 8b, c). Only occasional
monocyte-like cells associated with blood vessels are seen in the
brain parenchyma (Fig. 8b). By contrast, IBA1+ monocytes/
macrophages are detected in the meninges and choroid plexus in
both control and mutant embryos (Fig. 8c, d), consistent with our
ﬁndings in the adult brain (Fig. 7). There is also a reduction in the
IBA1+ macrophages in the fetal liver at the same stages of
development (Fig. 8e). We conclude that the Csf1rΔFIRE/ΔFIRE
mice recapitulate the phenotype of Csf1r−/− mice in early
hematopoiesis, producing a selective deﬁciency of yolk sac-
derived cells. The major macrophage populations that are
retained in the adult Csf1rΔFIRE/ΔFIRE mice (liver, lung, spleen,
intestine, dermis, etc.) are established late in gestation and post-
natally from monocytes derived from progenitors in the fetal
liver24,30,44,62,63. This conclusion is consistent with analysis of
expression of tissue macrophage-speciﬁc genes across an
embryonic gene expression time course65.
The chromatin landscape of Csf1r. Chromatin analysis and
ChIP-seq data identiﬁes at least four other Csf1r enhancers that
are active in mouse BMDM. Each is bound by JUN, STAT1, PU.1,
and CEBPA, which also bind cooperatively to many other
macrophage-associated enhancers (reviewed in ref. 9). To extend
these ﬁndings to other macrophage populations, we explored data
from a previous study that compared the enhancer proﬁles of
monocytes, microglia, and macrophages isolated from lung, liver,
spleen, intestine, and peritoneal cavity66. Peaks of H3K4me1
methylation (indicative of poised enhancers) appear throughout
the Csf1r locus and extend upstream into the neighboring Pdgfrb
gene (Fig. 9a). This extended H3K4me1 signal is almost unde-
tectable in neutrophils, which express Csf1r mRNA and Csf1r
reporter genes at low levels but do not express surface CSF1R11.
These additional elements lie outside the 3.5 kb promoter region,
and intron containing FIRE, used in production of Csf1r-reporter
genes (Fig. 9a). The ATAC-seq data revealed heterogeneity
amongst monocyte–macrophage populations. FIRE is clearly a
major peak of open chromatin detected in microglia and peri-
toneal macrophages, consistent with the impact of deletion of this
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element (Fig. 9b). By contrast, the signal associated with FIRE is
barely detectable in isolated lung and intestinal macrophages.
Indeed, the promoter-associated ATAC-seq signal is barely
detectable, consistent with relatively low expression of Csf1r
mRNA in these cells35,67,68 and lack of phenotype observed in
these tissues in Csf1rΔFIRE/ΔFIRE mice21. The ATAC-seq data in
Fig. 9b reveals multiple additional elements in cells that clear the
majority of CSF1 from the circulation (notably in KC and splenic
macrophages), that likely contribute to the redundancy of FIRE
and to the high level of Csf1r expression in these cell types11. One
of these elements includes the distal promoter element (DPE).
Located 5′ of the macrophage transcription start site, the DPE
also has tissue-speciﬁc functions64. It includes a separate tran-
scription start site cluster used by osteoclasts69. Expression of an
ampliﬁed Csf1r-ECFP (MacBlue) reporter transgene, in which
the DPE was deleted from the promoter, was undetectable in
most tissue macrophages64. The exceptions that retained reporter
gene expression were those populations impacted in the
Csf1rΔFIRE/ΔFIRE mouse; embryonic macrophages, BM progeni-
tors and monocytes, microglia, Langerhans cells, and peritoneal
macrophages. Therefore, we conclude that FIRE and the DPE
interact to control expression of Csf1r in embryonic macrophages
and in some tissue-resident macrophage populations but that
both are partly redundant.
Discussion
We show that the regulatory element, FIRE, is not required to
support Csf1r transcription in all macrophage populations. FIRE
is essential for the generation or maintenance of speciﬁc CSF1R-
dependent tissue macrophages, including those of the embryo, the
brain (microglia), skin (Langerhans cells), peritoneum, heart, and
kidney but redundant for expression of Csf1r mRNA in adult
mononuclear phagocyte populations in the intestine and lung.
FIRE is not required for the development of CSF1R-dependent
macrophages in other locations (i.e. dermis, spleen, liver, and
bone). The microglial population of the brain is established early
in development from yolk sac-derived progenitors. Apart from a
transient postnatal monocyte inﬂux, microglia are maintained
by self-renewal in a CSF1R-dependent manner70. The loss of
IBA1+ cells in Csf1rΔFIRE/ΔFIRE embryos (Fig. 8) indicates that
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Fig. 8 FIRE deletion results in a reduction of embryonic macrophages. a Formalin-ﬁxed parafﬁn-embedded embryos (E13) were stained with antibodies
against IBA1. Images are representative of seven embryos per genotype at E12, E12.5, and E13 and four repeat experiments. CP choroid plexus, LV lateral
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microglial development fails early in embryogenesis. This is
consistent with the apparent failure of macrophage production
from Csf1rΔFIRE/ΔFIRE EB in the E14 ESC model (Fig. 1f).
The relative independence of the large majority of tissue-
resident macrophages on the enhancer activity of FIRE begs the
question of why this element is so highly conserved across evo-
lution. Enhancer redundancy (i.e. the presence of shadow
enhancers), is widespread in eukaryotic developmental systems71.
Nevertheless, redundancy is often incomplete and the non-
overlapping functions presumably explain why multiple enhan-
cers within a locus are conserved across evolution71. The core
element within FIRE, conserved from reptiles to humans, con-
tains binding sites for AP1 and PU.1 that are essential for
enhancer activity14. Colocalization of AP1 and PU.1 motifs is a
feature of many mouse macrophage-speciﬁc constitutive enhan-
cers72. The non-redundant role of FIRE in Csf1r transcription in
only a subset of macrophages may be a consequence of tissue-
speciﬁc expression of transcription factors that bind selectively to
this region of the Csf1r locus. Candidate regulators have been
identiﬁed in many CSF1R-dependent macrophage populations.
For example, microglia are uniquely dependent upon speciﬁc
transcriptional regulators encoded by Sall173 and Irf874. Whilst
multiple open chromatin sites are bound by PU.1, CEBPA, and
other transcription factors in BMDM, IRF8 bound strongly and
exclusively to FIRE (reviewed in ref. 9). Irf8 mRNA is co-
expressed with Csf1r in the earliest committed monocyte pro-
genitors75 and upregulated in erythro-myeloid progenitors in
parallel with Csf1r during early embryonic development67. Renal
macrophages, which are also lost in Csf1rΔFIRE/ΔFIRE mice, along
with blood monocytes, share high gene expression of Irf8 with
microglia67. RUNX1 is another transcription factor that interacts
with FIRE in both mouse and human macrophages and controls
CSF1-dependent macrophage growth76. Accordingly, Runx1
mRNA is expressed in the earliest progenitors of CSF1R-positive
microglia44 and is amongst the transcription factors down-
regulated in the hippocampus in Csf1rΔFIRE/ΔFIRE mice (Supple-
mentary Data 1).
CSF1R deﬁciency causes embryonic or perinatal death in most
mouse strains and the few surviving Csf1r mutant mice have
numerous developmental abnormalities77. The Csf1rΔFIRE/ΔFIRE
mice that are born survive and thrive. Aside from survival,
other major differences between the pleiotropic impacts of
Csf1rΔFIRE/ΔFIRE and Csf1r−/− mutations4,77 are clearly related to
the selective retention of most Csf1r-dependent macrophage
populations in mice with the FIRE deletion. The expression
proﬁling of the hippocampus supports the view that trophic and
phagocytic functions attributed to microglia can be compensated
in part by other cells. Notably, neuronal development, including
expression of markers such as Cux1, is unaffected by the complete
loss of Csf1r expression. This observation argues strongly against
a functional role for Csf1r in neuronal progenitors58 and instead
supports that Csf1r is expressed and functional only in micro-
glia19. So, we suggest that the reported developmental and
homeostatic roles of Csf1r-dependent macrophages, including
microglia and those of the epidermis, peritoneum, kidney, and
heart are at least partly redundant. By extension, the loss of most
peripheral macrophages and the associated systemic impacts of
that loss must contribute to the severe brain developmental
abnormality observed in Csf1r−/− mice19,78. Severe postnatal
growth retardation is a shared feature of Csf1 and Csf1r mutant
mice and rats4,5 and is a consequence of impacts on the growth
hormone (GH)/insulin-like growth factor 1 (IGF1) axis (reviewed
in ref. 79). By contrast to the Csf1r-deﬁcient mice, liver macro-
phages develop normally in Csf1rΔFIRE/ΔFIRE animals (Fig. 4a and
Supplementary Fig. 4a) and somatic growth, as well as the
male–female sexual dimorphism in body weight gain, is unaf-
fected by the mutation. In Csf1 mutant rats, there was no post-
natal surge in circulating IGF179) and the Csf1r mutation in rats
reduced expression of both Ghr and Igf1 mRNA in the liver5.
Circulating IGF1 in turn crosses the blood brain barrier and
regulates many aspects of neuronal health (reviewed in ref. 80).
In overview, our objective in this study was to investigate the
role of a conserved enhancer in a key macrophage-expressed
gene. We have conﬁrmed the functional importance of FIRE in
speciﬁc macrophage populations. In the process, we have gener-
ated a unique mouse model in which to identify non-redundant
functions of speciﬁc resident tissue macrophages, especially those
of the brain, heart, skin, kidney, and peritoneum, in mice that are
otherwise healthy and fertile.
Methods
CRISPR design and plasmid preparation. gRNAs were designed to complement
the ﬂanking regions of the FIRE element of intron 2 (from 2646 to 3015 bp
downstream of the end of exon 2; NCBI Reference Sequence: NM_001037859.2)
using the online tool at http://crispr.mit.edu. Table 1 shows the guides designed,
the corresponding protospacer-adjacent motif (PAM) and the complementary
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Fig. 9 Chromatin landscape of the mouse Csf1r locus. ChIP-seq and ATAC-
seq data for the 100 kb window surrounding mouse Csf1r for each of the
isolated myeloid cell populations shown was extracted from the primary
data generated in Lavin et al.66. a ChIP-seq data showing the location of
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BbSI-overhang sequences. Top and bottom oligonucleotides corresponding to each
gRNA were aligned, phosphorylated, and cloned into the pSpCas9(BB)-2A-GFP
(Px458) plasmid (Addgene), and transformed into competent DH5α E. coli. Fol-
lowing veriﬁcation of gRNAs insertion by Sanger sequencing, plasmids were
puriﬁed using endotoxin-free MaxiPrep (QIAGEN).
Cell culture. RAW 264.7 macrophages (ATCC® TIB-71™) were cultured on
Sterilin-plastic dishes in RPMI 1640 medium (Sigma) supplemented with 10%
endotoxin-free FBS (GE Healthcare), 2 mM GlutaMAX (Invitrogen), 25 U/mL of
penicillin, and 25 µg/mL of streptomycin (Gibco). Cells were incubated at 37 °C in
a 5% CO2 humidiﬁed incubator. E14 (129P2/OlaHsd) mouse ESC (ATCC® CRL-
1821™) were cultured on porcine gelatin-coated (Sigma) ﬂasks in GMEM (Invi-
trogen) supplemented with 10% ESC-tested FBS (Hyclone), 2 mM GlutaMAX
(Invitrogen), 1X MEM non-essential amino acids, 1 mM sodium pyruvate, 0.1 mM
2-mercaptoethanol (Gibco), and 100 U/mL leukemia inhibitory factor (LIF,
Merck), at 37 °C in a 5% CO2 humidiﬁed incubator.
Generation of CRISPR/Cas9 deletions in vitro. E14 cells were passaged twice
and plated at 8 × 104 cells/cm2 for 24 h prior to transfection. Cells were transfected
with a total of 2 µg DNA (i.e. pairs of Cas9-2A-EGFP vectors, each expressing
single gRNAs: US1+DS1 or DS2) using the Amaxa P3 Primary cell 4D-
Nucleofector X Kit (Lonza) and incubated with supplemented GMEM for 36 h.
Cells were then resuspended in Dulbecco’s phosphate buffered saline (DPBS,
Sigma), diluted in sterile Baxter water (TPS Healthcare/Baxter), supplemented with
2% FBS and kept at 4 °C. The GFP+ cells were collected with a FACS Aria IIIu cell
sorter (BD). To generate single cell clones of CRISPR-modiﬁed E14 cells, sorted
pools of GFP+ cells were plated on 0.1% gelatin-coated 100 mm culture dishes at a
density of 18 cells/cm2 and single colonies picked approximately 2 weeks later.
RAW 264.7 cells (5 × 106) were resuspended in 250 µL of culture medium con-
taining 10 µL of DPBS ± 20 µg DNA (as pairs of FIRE-targeting Cas9-2A-EGFP
vectors, as speciﬁed above) and incubated at RT for 10 min. Electroporation was
performed in 0.4 cm electroporation cuvettes (BioRad) using the BioRad Gene
Pulser II (BioRad), at 320 V and a capacitance of 950 µF. Cells were cultured for
36 h and GFP+ cells were single-cell sorted into polystyrene ﬂat-bottom 96-well
plates, using a FACS Aria IIIu cell sorter (BD).
PCR analysis and sequencing of transfected E14 ESC and RAW 264.7 cells.
Isolation of DNA from sorted pools of GFP+ cells (either E14 ESC or RAW 264.7
cells), or from cells cultured in plates other than 96-well plates was performed with
the QIAGEN DNeasy Blood and Tissue Kit (QIAGEN), according to the manu-
facturer's instructions. Genomic DNA from single-cell-derived clones cultured in
96-well plates was isolated by adding a 1:1 mix of DirectPCR Lysis Reagent (Viagen)
and nuclease-free water (Invitrogen) supplemented with 20 µg of Proteinase K
(QIAGEN), per well. Cells were incubated in a heated orbital shaker at 200 rpm and
55 °C, for 12 h and Proteinase K was inactivated at 85 °C for 45min. Conventional
PCR was performed using 50 ng DNA per reaction, Taq DNA polymerase (Invi-
trogen) and the primers F-5′: GCTGCCCTGTCACTGTGTA and R-5′:
TCGTTTCCCATCCCAGGA, at an annealing temperature of 55 °C. PCR products
were run by electrophoresis to obtain a Csf1r+/+ of 925 bp, or Csf1r ΔFIRE/ΔFIRE
amplicons of either 485 bp (CRISPR pair: US1 and DS1) or 507 bp (CRISPR pair:
US1 and DS2). PCR amplicons were separated by standard electrophoresis, puriﬁed
with the QIAquick PCR puriﬁcation kit (QIAGEN) and then sequenced using the
oligonucleotides listed in Supplementary Table 1.
DNA isolation and genotyping. Mouse ear biopsies were digested overnight at
50 °C, in mouse biopsy buffer containing 100 mM Tris–HCl (Sigma) pH 8.5, 0.2%
SDS (Ambion), 200 mM NaCl (Sigma), 5 mM EDTA (Ambion), and 160 µg Pro-
teinase K (QIAGEN). Digested tissues were centrifuged at 12,000×g for 15 min at
4 °C and DNA was precipitated through the isopropanol–ethanol method. DNA
pellets were dried at RT, resuspended in nuclease-free water and quantiﬁed using a
Nanodrop™ 1000 (Thermo Fisher Scientiﬁc). PCR ampliﬁcation was performed as
described above and products were puriﬁed using the QIAquick PCR puriﬁcation
kit (QIAGEN) and sequenced using the oligonucleotides listed in Supplementary
Table 1.
Phagocytosis assay. RAW 264.7 cells were cultured in high glucose DMEM
(Gibco) supplemented with 10% endotoxin-free FBS (GE Healthcare) and 1 mM
GlutaMAX (Life Technologies). Cells were incubated at 37 °C for 2 h in the pre-
sence of pHrodo® Red E. coli BioParticles® (Thermoﬁsher) at a ratio of 100 µg/106
cells. Negative control samples were incubated on ice. Cells were analyzed using the
BD LSR Fortessa ﬂow cytometer. Dead cells were identiﬁed and excluded based
upon DAPI uptake.
Flow cytometry. Cells were analyzed by ﬂow cytometry using standard procedures.
Inhibition of non-speciﬁc binding was achieved by incubating the cells for 30 min
on ice in puriﬁed anti-CD16/32 (1 µg/mL, BioLegend, 101302) or hybridoma
2.4G2 supernatant. All antibodies are listed in Supplementary Table 2. Where
indicated, cells were ﬁxed and permeabilized prior to staining using the Leuco-
permTM kit (BioRad). Blood was processed using the Uti-Lyse reagent (Agilent).
Data analysis was performed in FlowJo® v10.0 (Tree Star). Gates were determined
with isotype controls or FMO for all experiments.
Differentiation of ESC-derived macrophages. E14 ESCs were harvested and
plated at a density of 5 × 106 cells per 50 mm Sterilin-plastic dishes, using culture
medium without LIF. After 4 days, cell debris was removed using 70 µm cell
strainers. Fresh culture medium containing 50 ng/mL of rhCSF1 (a gift from
Chiron, USA) and 10 ng/mL of mouse recombinant interleukin 3 (IL3, Invitrogen)
was added. After 7 days the culture medium was replaced to contain 100 ng/mL of
rhCSF1 for 10 days, without IL3.
Generation of Csf1rΔFIRE/ΔFIRE mice. Ethical approval was obtained from The
Roslin Institute’s and The University of Edinburgh’s Protocols and Ethics Com-
mittees, under the authority of a UK Home Ofﬁce Project License under the
regulations of the Animals (Scientiﬁc Procedures) Act 1986. Mice were bred and
housed under speciﬁc pathogen-free conditions. Csf1rΔFIRE/ΔFIRE mice were pro-
duced by pronuclear injection of oocytes with the plasmids encoding FIRE-
CRISPRs US1 and DS2 (10 µg of each) and Cas9 mRNA. Both donor and recipient
females were B6CBAF1/J (JAX™, stock number 100011). Founders were then
crossed to C57BL/6 mice and their offspring interbred.
Micro CT. Micro CT was performed on formalin-ﬁxed, parafﬁn-embedded dec-
alciﬁed femurs. Specimens were held in 1% agarose in a 20 mL universal tube
before mounting in a Skyscan 1172 desktop micro CT (Bruker). The tubes were
then scanned through 360° using a step of 0.28° between exposures. A voxel
resolution of 6.03 µm was obtained using the following control settings: 54 kV
source voltage, 185 µA source current with an exposure time of 1767 ms. A 0.5 mm
aluminum ﬁlter and two frame averaging were used to optimize the scan. After
scanning, the data was reconstructed using Skyscan software NRecon v1.6.9
(Bruker). The reconstruction thresholding window was optimized to encapsulate
the target image, with the same values used for all bones. Reconstructed bones were
oriented around their vertical axis using DataViewer v1.5.2.4 (Bruker). The tra-
becular region of bone 200 µm thick starting 100 µm proximal to the primary
spongiosa was identiﬁed, and volumetric analysis to determine the micro-
architecture of this region was performed using CTAn v1.16.4.
Histology and immunohistochemistry. Tissues were ﬁxed in 10% neutral buf-
fered formalin and processed into parafﬁn using standard procedures. For exam-
ination of tissue architecture, sections were stained with hematoxylin and eosin
(H&E) or Luxol fast blue. Femurs and tails were decalciﬁed in EDTA. Osteoclasts
were detected by staining sections with the tartrate-resistant acid phosphatase
(TRAP) kit (Sigma), according to instructions.
Goblet cells were stained by treating sections of small intestine with 1% periodic
acid for 7 min and incubating them in Schiff’s reagent for 15 min, with washes in
water between steps; followed by counterstaining for 15 s with Hematoxylin.
For immunohistochemistry, antigen retrieval was performed with Proteinase K
for 5 min at 37 °C prior to staining. Tissue-resident macrophages in spleen and
liver sections were detected by staining with the rat anti-mouse F4/80 monoclonal
antibody (1:600; AbD Serotec, MCA497G). For staining of adult brains, primary
antibodies were applied overnight at 4 °C in a humid chamber. These included
Table 1 CRISPR guide RNAs
Guide Top BbSI-ﬂanking sequence Guide sequence Bottom BbSI-ﬂanking sequence PAM
US1-top CACC 5' GAGTCCCTCAGTGTGTGAGA – AGG
US1-bottom – 3' TCTCACACACTGAGGGACTC CAAA –
DS1-top CACC 5' GGGATGACACAACGGTTTCC – TGG
DS1-bottom – 3' GGAAACCGTTGTGTCATCCC CAAA –
DS2-top CACC 5' CAATGAGTCTGTACTGGAGC – AGG
DS2-bottom – 3' GCTCCAGTACAGACTCATTG CAAA –
US upstream FIRE, DS downstream FIRE, PAM protospacer-adjacent motif
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chicken anti-GFAP (1:500; Cambridge Bioscience, 829401) and rabbit anti-SOX9
(1:500; Millipore, AB5535). Following three washes in PBS, ﬂuorescently
conjugated secondary antibodies were applied (1:500; Life Technologies) for 2 h at
RT, then slides were counterstained with DAPI for 10 min and mounted with
Fluoromount G (Cambridge Bioscience). For isolation of epidermal sheets,
dissected tail skin was incubated in 2 mg/mL Dispase II (Sigma) at 37 °C for
20 min. Epidermal skin samples were ﬁxed overnight in 4% PFA at 4 °C. After
washing with TBS, samples were incubated for 1 h at RT in permeabilization buffer
(PB)—TBS containing 0.25% gelatin from cold water ﬁsh skin (Sigma), 0.5% Triton
X100 (Sigma), and 5% heat-treated goat serum (Sigma). Epidermal samples were
then incubated in PB containing rat anti-mouse MHCII (Clone 2G9, 1:100, BD,
553621) and 1:30 goat anti-human Langerin (1:30, Thermo Fisher Scientiﬁc, PA5-
47250) overnight at 4 °C. Samples were washed ﬁve times for 1 h at RT in TBS
containing 0.02% Tween 20 (Fisher Scientiﬁc) (TBST) followed by incubation
overnight at RT with anti-goat and anti-rat Alexa Fluour secondary antibodies (Life
Technologies) diluted 1:500 in PB. After washing four times for 1 h in TBST,
epidermal sheets were counterstained with DAPI (Sigma) and mounted in Prolong
Gold (Life Technologies).
Frozen sections of 4% PFA perfused adult brains were processed and stained
with rabbit anti-IBA1 (1:500, Wako, 019-19741), rabbit anti-P2RY12 (Sigma, 1:125,
HPA013796), and Alexa Fluor® conjugated secondary antibodies using standard
procedures.
Dura mater were removed into ice-cold PBS, ﬁxed for 1 h in 4% PFA, treated for
30 min at 37 °C in PBS containing 20 mM EDTA and then blocked in 3% BSA,
0.3% Triton X100 in PBS for 30 min. Whole mount staining steps were performed
in blocking buffer containing rabbit anti-IBA1 overnight (1:1000, Wako, 019-
19741), goat anti-rabbit Alexa Fluor® 594 1 h (1:400, Life Technologies, A-11012),
Alexa Fluor® 647 anti-mouse CD169 1 h (Clone Siglec-1, 1:200, BioLegend,
142408), with washes in buffer in between incubations. Stained tissues were then
mounted onto glass slides with mounting medium and cover-slipped. Slides were
imaged via a LSM710 confocal microscope (Zeiss) using Zen software.
Image acquisition and quantiﬁcation. Whole-slide bright ﬁeld images were
acquired using the NanoZoomer slide scanner. Image analysis was performed with
the NDP.view software v2.4.26 (Hamamatsu) and with ImageJ v1.46h. For spleen
and liver, 10 regions of interest (ROI) were exported per sample as jpg format from
the NDP.view ﬁles. Signal was quantiﬁed from the whole area corresponding to
each ROI (i.e. each jpg ﬁle). For analysis of small intestine, individual villi were set
as a ROI in the jpg ﬁle derived from PAS-staining. Villus perimeter, as well as the
area and the number of Goblet cells (PAS+ cells) were quantiﬁed. Measurement of
villus length was performed in H&E images where 30 villi were measured per
sample, from the mucosal base adjacent to the crypts to the apex, using the “ruler”
function of the NDP.view v2.4.26 software. Entire brain tissue sections were imaged
using a Zeiss AxioScan SlideScanner and visualized with Zen2 software. Epidermal
tail sheets were imaged with a Zeiss LSM 710 confocal microscope and ZEN
software. For astrocyte analysis the images were obtained by z-stacks using a Zeiss
Axio Scan.Z1 (10× objective) and an Olympus 3i Spinning Disk confocal micro-
scope (30× silicone objective) using SlideBook software. For astrocytes counts, tiff
ﬁles from max projections were imported to Image J, and the images were con-
verted to 8-bit ﬂuorescence RGB tiff and thresholded. For nuclear counts, water-
shed segmentation on binary images was used to separate objects and then images
were analyzed. Two ﬁelds of view were quantiﬁed and then the mean was calcu-
lated and converted to mm2. To count the proportion of GFAP-positive cells, the
number of GFAP+ cells was divided by the number of SOX9+ nuclei.
Blood analysis. Blood was isolated through cardiac puncture, using syringe and
needle coated with 2% EDTA. Blood was collected into 2 mL EDTA tubes (BD
Vacutainer®) containing 1.8 mg of EDTA per mL of blood. Total blood cell counts
were performed using the ABX Pentra 60 hematology analyzer and differential
counts of WBC subsets were performed on blood smears.
BM isolation and cell culture. BM was isolated by ﬂushing femurs with RPMI
containing 5 mM EDTA. For ﬂow cytometry analysis, erythrocytes were not lysed
to prevent cleavage of CSF1R. For macrophage differentiation, erythrocytes were
lysed with RBC lysis buffer (BioLegend) and BM cells were cultured on Sterilin-
plastic dishes in the presence of rhCSF1 (at 100 ng/mL, a gift from Chiron) for
7 days. Fresh media containing rhCSF1 was added on Day 4.
Isolation of peritoneal cells. Cells for ﬂow cytometry analysis were isolated from
mice by lavage of the peritoneal cavity with PBS. Cells were centrifuged at 400×g
for 5 min at 4 °C prior to resuspension in PBS containing 2% endotoxin-free FBS
(GE Healthcare).
Preparation of organs for ﬂow cytometry. The spleen, liver, lung, heart, and
kidneys were prepared for ﬂow cytometry from non-perfused mice. Organs were
removed, chopped ﬁnely, and digested in RPMI containing 0.625 mg/mL col-
lagenase D (Roche), 0.85 mg/mL collagenase V (Sigma), 1 mg/mL dispase (Life
Technologies), and 30 U/mL DNase (Roche) for 22 min (lung) or 45 min (other
organs) in a shaking incubator at 37 °C. Organ preparations were passed through
100 µm cell strainers and centrifuged at 300×g for 5 min at 4 °C prior to resus-
pension in PBS containing 2% endotoxin-free FBS. Erythrocytes were then lysed
using RBC lysis buffer (BioLegend).
Isolation of intestinal cells. Single cell suspensions of small and large intestines
(colon) from non-perfused mice were prepared for ﬂow cytometry. Intestines were
opened longitudinally and cut into 2–3 cm segments in ice-cold PBS and intestinal
contents removed by gentle shaking. Tissue segments were incubated at 37 °C for
20 min whilst shaking in RPMI containing 3% endotoxin-free FBS (GE Health-
care), 20 mM HEPES (Gibco), 5 mM EDTA (Sigma), 1 mM DTT (Promega), and
100 U/mL polymyxin B (Sigma). Segments were transferred to RPMI containing
2 mM EDTA and 20mM HEPES and shaken by hand to ensure optimal dis-
sociation of epithelial cells and lamina propria leukocytes. Tissues were minced
with scissors and digested at 37 °C for 30 min, whilst shaking in RPMI containing
20 mM HEPES, 0.425 mg/mL Collagenase V (Sigma), 0.625 mg/mL Collagenase D
(Roche), 1 mg/mL Dispase (Gibco), and 30 µg/mL DNase (Roche). Cell suspen-
sions were passed through 70 µm then 40 µm cell strainers in RPMI containing
10% endotoxin-free FBS and 100 U/mL polymyxin B. After centrifugation at 400×g
at 4 °C for 5 min, including a wash step, cells were resuspended in PBS containing
2% FBS for ﬂow cytometry.
Myelin depletion of brains and isolation of cells. Myelin-depleted brain sus-
pensions were prepared from saline perfused mice for ﬂow cytometry. Whole
brains were ﬁnely minced with scissors in ice-cold Hank’s balanced salt solution
(HBSS, Sigma, without calcium or magnesium) and centrifuged at 400×g for 5 min
at 4 °C. Minced brains were then digested in HBSS containing 50 U/mL Col-
lagenase IV (Gibco), 100 µg/mL Nα-Tosyl-L-lysine chloromethyl ketone hydro-
chloride (Sigma), 5 U/mL DNase I (Roche) and 8.5 U/mL Dispase (Gibco) for 1 h
at 37 °C whilst shaking. The digested tissue was homogenized in a glass Dounce
tissue grinder for 20 passes and an equal volume of HBSS containing 10%
endotoxin-free FBS was then added. After centrifugation at 400×g for 5 min at 4 °C,
the cell pellet was resuspended in 16 mL 35% Percoll in HBSS, overlaid with 10 mL
HBSS and incubated on ice for 5 min. The gradient was centrifuged at 800×g for
45 min at 4 °C with no brake. The cell pellets were then resuspended in PBS
containing 2% FBS for ﬂow cytometry.
RNA isolation and microarrays. For RNA isolation, tissues from saline perfused
mice were snap frozen, and subsequently disrupted in the Precellys24 Homo-
genizer® (Bertin Instruments). RNA isolation was performed using the RNeasy Plus
Mini kit (QIAGEN). Library preparation and hybridization to the Affymetrix
Mouse Gene 1.0 ST array was performed by Edinburgh Genomics, University of
Edinburgh. CEL ﬁles were RMA normalized and annotated in R/Bioconductor.
Analysis of differential expression was performed using the Affymetrix Tran-
scription Analysis Console (Thermo Fisher).
Analysis of hippocampi microarray data. These data were interrogated with sets
of genes whose expression is highly enriched in speciﬁc cell types of the brain
(astrocytes, oligodendrocytes, microglia, neurons, brain endothelial cells). These
sets were curated from published RNA-seq data (GEO, accession number
GSE73721) describing the transcriptome of astrocytes, oligodendrocytes, microglia,
neurons, and brain endothelial cells60. The inclusion criteria consisted of (a) being
expressed at least ﬁve-fold higher in the cell type of interest than all other cell types
and (b) being expressed at least 50 FPKM to enable robust detection in the mixed
cell type environment of a whole hippocampus.
cDNA synthesis and quantitative real-time PCR. Complementary DNA (cDNA)
was synthesized from RNA using the SuperScript III. First-Strand Synthesis System
and remaining template was removed by incubation with RNase H (Invitrogen).
Oligonucleotides were designed in Primer3 v4.0.0 (available at http://bioinfo.ut.ee/
primer3/). Real-time qPCR reactions were performed using the Fast SYBR green
master mix and the 7500 Fast System (Applied Biosystems). Analysis was per-
formed with 7500 software v2.0.6 (Applied Biosystems, Life Technologies Cor-
poration). For analysis of relative changes in gene expression, data were normalized
according to the 2−ΔΔCT method. Hypoxanthine guanine phosphoribosyl trans-
ferase (Hprt) was used as a loading control/housekeeping gene. Oligonucleotide
sequences are listed in Supplementary Table 3.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the ﬁndings in this study are available within
the article and its Supplementary Information ﬁles or from the corresponding authors on
reasonable request. The RNA expression datasets are publicly available in the gene
expression omnibus (GEO; https://www.ncbi.nlm.nih.gov/gds) via the accession number
GSE108207. Published ATAC-seq and ChIP-seq data used in this manuscript is available
via GEO accession number GSE63341. The RNA-seq data used to curate cell type speciﬁc
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genes in the brain is available via GEO accession number GSE73721. The data used to
identify microglia-enriched genes versus macrophage genes is available via GEO
accession number GSE48579. All other data contained within this manuscript is located
in the Source Data excel ﬁle.
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